# The Adverse Event of Mitotane Therapy in Patients With Adrenocortical Carcinoma

> **NCT05839886** · — · UNKNOWN · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 50 (estimated)

## Conditions studied

- Adrenocortical Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05839886
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05839886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05839886, "The Adverse Event of Mitotane Therapy in Patients With Adrenocortical Carcinoma". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT05839886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*